Balchem (BCPC) Expected to Announce Quarterly Earnings on Friday

Balchem (NASDAQ:BCPC) is anticipated to announce its earnings results before the market opens on Friday, February 21st. Analysts expect the company to announce earnings of $1.11 per share and revenue of $241.85 million for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Balchem Stock Up 2.5 %

BCPC opened at $163.14 on Friday. The business has a 50 day moving average price of $163.97 and a two-hundred day moving average price of $169.81. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. The company has a market cap of $5.30 billion, a PE ratio of 43.85, a P/E/G ratio of 4.42 and a beta of 0.69. Balchem has a 52 week low of $137.69 and a 52 week high of $186.03.

Balchem Increases Dividend

The business also recently disclosed an annual dividend, which was paid on Friday, January 17th. Shareholders of record on Thursday, December 26th were paid a dividend of $0.87 per share. The ex-dividend date was Thursday, December 26th. This is an increase from Balchem’s previous annual dividend of $0.79. This represents a yield of 0.4%. Balchem’s dividend payout ratio is currently 23.39%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright increased their target price on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, November 4th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.